Home / Market News / $BMY
benzinga Macro/Central Bank Impact 65/100 ● positive

Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views

Jul 30, 2026, 4:02 PM UTC · Primary ticker $BMY

This filing provides a broad overview of Thursday's market activity, highlighting Bristol-Myers Squibb's strong earnings and positive market sentiment despite mixed economic data. The report details sector performance, individual stock movements, commodity prices, and global market trends, offering a snapshot of the day's financial landscape.

This filing provides a comprehensive daily market recap, with Bristol-Myers Squibb's strong earnings serving as a key corporate catalyst. The broader market saw gains, particularly in information technology, despite mixed economic indicators like slowing personal income and spending, and a contraction in the PCE price index. This suggests that corporate performance and specific M&A news (like Marketaxess) are currently outweighing some of the softer macroeconomic data. For traders, this highlights the importance of individual company fundamentals and sector-specific trends in the short term, while the mixed economic data could signal potential long-term headwinds or opportunities for a dovish shift from the Fed.

$BMY positive Exceeded earnings and sales expectations, raised FY2026 guidance
$CMCO positive Upbeat quarterly results
$MKTX positive Acquisition by Intercontinental Exchange
$XRX positive Better-than-expected quarterly financial results
$CAPR negative FDA Advisory Committee voted against investigational drug
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.